GNI GROUP LTD.
Personal information protection policy
Terms of Use
Site Map
Career
Japanese
Top Page
About Us
R&D
Investor Relations
Contact Us
[Link to Japanese page]
Top Page
News Release
Release in 2011
News Release
Release in 2011
12/28/2011
Notice for Large Volume Exercise of the 35th Round of Stock Options
12/19/2011
Notice for Large Volume Exercise of the 35th Round of Stock Options
12/14/2011
Notice for Large Volume Exercise of the 35th Round of Stock Options
12/12/2011
Notice for Large Volume Exercise of the 35th Round of Stock Options
12/07/2011
Notice of Payment for the 35th Round of Stock Options
11/21/2011
GNI Announces Third-Party Allotment and the Issuance of the 35th Round of Stock Options with Moving Strike
09/22/2011
China SFDA Approves F647/Pirfenidone for the Treatment of Idiopathic Pulmonary Fibrosis
08/26/2011
(Added)Notice for Acquisition of Beijing Continent Pharmaceutical Co. Ltd.
08/24/2011
Notice of Increasing the Capital of Shanghai Genomics
08/02/2011
GNI Receives Patent Allowance on F351 and F647
07/13/2011
Notice for Acquisition of Beijing Continent Pharmaceutical Co. Ltd.
07/13/2011
Notice for Dissolving Term Sheet to Acquire Hengshan Pharmaceuticals Co. Ltd.
07/07/2011
GNI Group Files IND for Drug on Liver Failure
03/29/2011
Notice of Changing Corporate Name
03/28/2011
Notice of Granting Paid Stock Option
1
2
Next >
News Release
Information
2022
2021
2020
2019
2018
2017
2016
2015
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
Event Calendar
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
Release
2015
2014
2013
2012
2011
2010
2009
2008
2007